TREN
Contact us

Secondary Packaging Alone of Imported Bottled Medicines Is Not Manufacturing; Export-Registered Delivery Is Not Possible

VAT · Imports and exportsSecondary Packaging Alone of Imported Bottled Medicines Is Not Manufacturing; Export-Registered Delivery Is Not PossiblePrivate ruling · 11 September 2024
Rast note

A pharmaceutical company holding an industrial registry certificate for injectable medicines labels and boxes (secondary packaging) at its own facility medicines imported already bottled, making them ready for sale, and asked whether it can deliver them under export registration under VATL Art. 11/1-c.

The Administration's view:

  • Manufacturers can benefit from deferral-cancellation only for goods they produce themselves; it does not apply to goods bought ready-made and resold.
  • Only secondary packaging (labelling, boxing) of imported bottled medicines without any other processing does not constitute a manufacturing stage.
  • Therefore delivery of these medicines cannot be treated within VATL Art. 11/1-c.

The ruling is relevant to manufacturers packaging imported products and delivering them to exporters.

ShareLinkedInWhatsAppEmail

Full text

Subject: Whether imported medicine can be packaged and delivered under export registration
Unofficial translation by Rast Partners. The Turkish original published by the Revenue Administration prevails.

From examination of the ruling request forms referred to in references (a), (c) and (ç), it is understood that, stating that the production subject of the Industrial Registry Certificate dated … numbered … issued in your Company's name is "injectable liquid syringe/cartridge (syringe/cartridge), injectable lyophilised vial (lyophilised), injectable liquid vial (liquid)", that some of the medicines imported by your Company reach you bottled but with secondary packaging (labelling, boxing) not completed, and that the medicine bottles are made ready for sale at your Company's production facility by subjecting them to secondary packaging without changing their foreign origin, our Presidency's opinion is requested on whether these medicines imported and packaged by your Company can be delivered under export registration within Article 11/1-c of the Value Added Tax (VAT) Law.

Under Article 11/1-c of VAT Law No. 3065, VAT on goods delivered to exporters by manufacturers on condition of export will not be paid by the exporters; this tax, not collected by the taxpayers but to be declared in the return for the relevant period, will be assessed, accrued and deferred by the tax office; and the deferred tax will be cancelled if the goods are exported within 3 months from the beginning of the month following the date of delivery to the exporter.

On the other hand, explanations on the deferral-cancellation application for export-registered deliveries are given in section (II/A-8.) of the VAT General Application Communiqué, and section (II/A-8.3) titled "Sellers Benefiting from the Deferral-Cancellation Application" of that Communiqué states:

"Sellers qualifying as "manufacturers" can benefit from the deferral-cancellation application.
The manufacturer must:
- be registered in the industrial registry and hold an industrial registry certificate, or hold any of the farmer registration certificate, food business registration certificate or business approval certificates (producer certificate) obtained from the Ministry of Food, Agriculture and Livestock, (These certificates will be referred to as "manufacturer certificate" in later sections.)
- be registered with the relevant professional chamber,
- employ the number of workers and have the necessary equipment stipulated in the Industrial Registry Communiqués in force in the period of production, or have the production infrastructure in the capacity report.
...
Manufacturers may buy part of the goods they deliver under export registration ready-made from the market. In this case, deferral-cancellation is applied for the goods the manufacturers produce themselves. Deferral-cancellation is not applied for goods they buy ready-made from the market and sell.
Example: A joint stock company produced 6,000 of the 10,000 shirts for which it established an export-registered sales connection itself and bought 4,000 ready-made from the market. Deferral-cancellation is applied for the 6,000 shirts of which this taxpayer is the manufacturer among the 10,000 shirts it delivers to the exporter under export registration, and this application cannot be used for the remaining 4,000 shirts.
In this case, manufacturers selling to exporters may show the goods they produce themselves and the goods they buy ready-made from the market separately on the invoice they issue, or may issue separate invoices for these goods."

Accordingly, since only secondary packaging (labelling, boxing) of bottled medicines imported from abroad, carried out by your Company at your production facilities without any other processing, does not constitute one of the manufacturing stages, it is not possible to treat the delivery of these products within Article 11/1-c of VAT Law No. 3065.

For your information.

(*) This ruling has been issued under Article 413 of Tax Procedure Law No. 213.
(**) This ruling is invalid if incorrect information has been provided on this matter while it is under tax examination, judicial review or settlement.
(***) If you act in accordance with this ruling issued at your request and tax has to be assessed as a result, no tax penalty will be imposed on you and no late payment interest will be calculated on the tax assessed.

Private rulings bind only the taxpayer who requested them; similar cases should be assessed separately. The English text is an unofficial translation prepared by Rast Partners; the Turkish original published by the Revenue Administration prevails.